Durham, NC
We leverage our patent-pending technology to produce nutritionally equivalent breastmilk from cultured human mammary cells. With Biomilq, families can achieve the recommended six months of exclusive breastfeeding while alleviating the climate impacts of bovine-based infant formula.
biomilq.comThese are collections BIOMILQ is a part of. Click on the collection name to view similar companies.
Series A
$21,000,000
Seed
$3,500,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on BIOMILQ.